Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ORINASE DIAGNOSTIC

TOLBUTAMIDE SODIUM

Standard Dose
EQ 1GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview ORINASE DIAGNOSTIC is listed in Drugs@FDA under application 012095 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient TOLBUTAMIDE SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 2000-04-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORINASE DIAGNOSTIC is listed in Drugs@FDA under application 012095 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient TOLBUTAMIDE SODIUM Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 2000-04-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.